Eyenovia, Inc.
USD7.56
+0.29 (+3.99%)
CEO
Michael M. Rowe
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.54
Prev. Close
$7.27
Day Low
$7.28
Day High
$7.82
52W Low
$0.85
52W High
$124.80
Market Cap
$0.04B
Volume
0.03M
| -0.1 |
| 31 Dec 2023 | FY | -322.6% | -719859.9% | -302.9% | -94.7% | 1.79 | 2.17 | -0.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -162.5% | -90.3% | 0.59 | 6.13 | -0.1 |
| 31 Dec 2021 | FY | 88.6% | -91.3% | -62.4% | -40.4% | 0.35 | 1.97 | -0.2 |
| 31 Dec 2020 | FY | 60.0% | -988.5% | -129.2% | -58.3% | 0.03 | 1.83 | -0.1 |
| -0.1 |
| 30 Sept 2025 | Q3 | 100.0% | 2190.2% | 9.4% | 8.0% | 0.12 | 2.25 | 0.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -23.3% | -15.6% | 0.23 | 0.91 | -0.3 |
| 31 Mar 2025 | Q1 | 99.7% | -23665.3% | 35.9% | -58.2% | -1.15 | 0.34 | -0.5 |
| 31 Dec 2024 | Q4 | -10939.5% | -71031.1% | 152.4% | -544.1% | -0.86 | 0.17 | -0.1 |
| 30 Sept 2024 | Q3 | -8055.2% | -485406.3% | -212.1% | -34.6% | 3.50 | 0.74 | -0.2 |
| 30 Jun 2024 | Q2 | -2067.3% | -48856.1% | 466.4% | -58.2% | -6.61 | 0.46 | -0.1 |
| 31 Mar 2024 | Q1 | -3966.2% | -218748.3% | -600.9% | -41.7% | 9.15 | 0.88 | -0.1 |
| 31 Dec 2023 | Q4 | 0.0% | -307730.3% | -88.5% | -27.7% | 1.79 | 2.17 | -0.2 |